Hilleman announces Dr Raman Rao as new CEO
Dr Rao will replace Dr Davinder Gill, who will leave his current role as CEO on 31st January, 2020, after more than eight years at…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dr Davinder Gill
EVI and Hilleman Lab partner to assess Shigella vaccine
ShigOraVax will be the first-ever Indian vaccine developed to benefit people living in low and middle-income settings.
Hilleman Laboratories’ preclinical trial report on Hib vaccine offers hope to millions of children
The unique formulation will not only be cost effective but also scalable for commercial manufacturing
Global vaccine research and…
Hilleman Laboratories’ Thermostable technology extends its support towards other vaccines
The company plans to support India’s aim of achieving 90 per cent coverage through its expanded programme by 2020